Market Insights: Nasdaq Trends and Capricor Surge (02.10.2024 22:33)
Explore the latest Nasdaq trends, Capricor Therapeutics surge, and investor movements in PepsiCo and iShares ETFs.
- Latest
- Trending
Explore the latest Nasdaq trends, Capricor Therapeutics surge, and investor movements in PepsiCo and iShares ETFs.
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Biotech firm Eradivir raises $10.25M for Phase 2a EV25 study, aiming to revolutionize influenza treatment.
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Moderna shares dip as R&D spending reduces, focusing on FDA approval for 10 key products including RSV and cancer treatments.
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
Exploring AstraZeneca's strategic investments in digital health to enhance R&D, patient care, and partnerships.
Biotech firms restructure with layoffs as FDA approves new drugs, exemplifying industry challenges and opportunities.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.